Literature DB >> 3010676

Role of the substantia nigra in GABA-mediated anticonvulsant actions.

K Gale.   

Abstract

The relationship between cerebral GABA content and susceptibility to seizures is addressed from the point of view of specific brain loci at which GABA synapses may control convulsive activity. The substantia nigra (SN) has been identified as a critical site at which GABA-agonist drugs act to reduce susceptibility to a number of types of experimentally induced generalized seizures. Moreover, the ability of GABA-elevating agents to protect against seizures in the maximal electroshock model is directly correlated with increases in GABA specifically in the nerve-terminal compartment of SN. Studies with 2-deoxyglucose indicate that a marked increase in metabolic activity in SN is a common feature of several types of generalized seizures; it is possible that some of this increased activity is associated with GABAergic nerve terminals that become activated in an attempt to suppress seizure spread. Because GABA has been shown to inhibit nigral efferents, it is likely that GABA terminals inhibit nigral projections that are permissive or facilitative to seizure propagation. In support of this, bilateral destruction of SN attenuated clonic and tonic chemoconvulsant and electroshock seizures. Other treatments capable of reducing nigral output, namely opiate agonists (morphine and D-Ala-Met-enkephalin), and substance P antagonist analogs, were also found to have anticonvulsant effects when applied bilaterally into SN. Thus, the seizure-facilitating nigral efferents may be subject to inhibition by both GABA and opiates and may normally be driven by substance P. Of the various outputs from SN, the GABAergic projections to thalamus, reticular formation and/or superior colliculus are most likely responsible for influencing seizure propagation. Experimental evidence does not indicate a significant role of pars compacta nigrostriatal dopamine neurons for controlling the various types of seizures subject to nigral influence. We propose that the inhibition of the GABAergic outputs from SN pars reticulata can suppress the progression of seizure discharge through circuits involving the target areas of these outputs. Because chemical or electrical stimulation of SN does not initiate convulsions, it appears that seizure activity generated elsewhere in the brain may be amplified or sustained by activity in these nigral outputs.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010676

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  19 in total

1.  Delta-sleep-inducing peptide and its analogs and the serotoninergic system in the development of anticonvulsive influences.

Authors:  A A Shandra; L S Godlevskii; A I Brusentsov; V P Petrashevich; R S Vast'yanov; B Nikel; I I Mikhaleva
Journal:  Neurosci Behav Physiol       Date:  1998 Sep-Oct

2.  The role of the substantia nigra pars reticulata in kindling resistance in rats with genetic absence epilepsy.

Authors:  Ozlem Akman; Medine I Gulcebi; Nihan Carcak; Sema Ketenci Ozatman; Tugba Eryigit; Solomon L Moshé; Aristea S Galanopoulou; Filiz Yilmaz Onat
Journal:  Epilepsia       Date:  2015-10-16       Impact factor: 5.864

3.  Differential actions of serotonin, mediated by 5-HT1B and 5-HT2C receptors, on GABA-mediated synaptic input to rat substantia nigra pars reticulata neurons in vitro.

Authors:  I M Stanford; M G Lacey
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

4.  Substantia nigra lesions in mercaptopropionic acid induced status epilepticus: a light and electron microscopic study.

Authors:  J Towfighi; W A Kofke; B K O'Connell; C Housman; J M Graybeal
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Substantia nigra damage induced by ischemia in hyperglycemic rats. A light and electron microscopic study.

Authors:  K Inamura; Y Olsson; B K Siesjö
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

6.  Valproate-induced rest tremor and parkinsonism.

Authors:  José Fidel Baizabal-Carvallo; Marlene Alonso-Juarez
Journal:  Acta Neurol Belg       Date:  2019-11-13       Impact factor: 2.396

7.  Deep brain stimulation for epilepsy.

Authors:  Casey H Halpern; Uzma Samadani; Brian Litt; Jurg L Jaggi; Gordon H Baltuch
Journal:  Neurotherapeutics       Date:  2008-01       Impact factor: 7.620

8.  Metabolic and neuroanatomical correlates of barrel-rolling and oculoclonic convulsions induced by intraventricular endothelin-1: a novel peptidergic signaling mechanism in visuovestibular and oculomotor regulation?

Authors:  P M Gross; R J Beninger; S W Shaver; D S Wainman; F J Espinosa; D F Weaver
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

9.  Vigabatrin in epilepsy in mentally retarded patients.

Authors:  R Matilainen; A Pitkänen; T Ruutiainen; E Mervaala; P Riekkinen
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

10.  Inhibitory and excitatory amino acids in cerebrospinal fluid of chronic epileptic patients.

Authors:  A Pitkänen; R Matilainen; T Halonen; R Kutvonen; P Hartikainen; P Riekkinen
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.